• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Welkin Health, Humana Partner on New Telephonic Diabetes Program

by Jasmine Pennic 07/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Welkin Health, Humana Partner on New Telephonic Diabetes ProgramWelkin Health, a San Francisco-based digital health company that helps healthcare organizations provide care to patients with chronic illness has inked a partnership with Humana on a new telephonic diabetes outreach program for the elderly. Welkin Health’s platform supports care organizations that emphasize care coordination as a critical element of quality improvement and cost reduction. Healthcare organizations can now enable members of the care team to seamlessly manage daily outreach to hundreds of people with chronic illness through telephone, SMS, and Welkin’s smartphone app for patients.  

As part of the partnership, Humana will utilize Welkin Health’s Coaching platform for a new telephonic diabetes program in San Antonio and New Orleans that will give patients access to personalized diabetes support. “Providing diabetes education and support for senior citizens is challenging to do in a convenient and accessible way,” said Sarah Ahmad, Vice President, Consumer Health Solutions at Humana. The CDC reports that more than half of adults in America have a chronic health condition, and almost 90% of healthcare spending now goes to chronic disease management such as diabetes. In this environment, forward-thinking health insurers like Humana are investing in the programs and tools necessary to manage large populations of patients with chronic illness.

In addition to the Humana partnership, Welkin has also raised a $2M seed round of financing led by investors including Rock Health, Asset Management Ventures and the Mayo Clinic. The additional capital will be used to expand Welkin’s care coordination platform to include chronic disease care for hypertension, COPD, and congestive heart failure, and also go towards further developing tools for administrators.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Welkin Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |